Antimicrobials for food and feed; a bacteriocin perspective.


Journal

Current opinion in biotechnology
ISSN: 1879-0429
Titre abrégé: Curr Opin Biotechnol
Pays: England
ID NLM: 9100492

Informations de publication

Date de publication:
02 2020
Historique:
received: 30 09 2019
revised: 30 11 2019
accepted: 20 12 2019
pubmed: 23 1 2020
medline: 28 8 2020
entrez: 23 1 2020
Statut: ppublish

Résumé

Bacteriocins are natural antimicrobials that have been consumed via fermented foods for millennia and have been the focus of renewed efforts to identify novel bacteriocins, and their producing microorganisms, for use as food biopreservatives and other applications. Bioengineering bacteriocins or combining bacteriocins with multiple modes of action (hurdle approach) can enhance their preservative effect and reduces the incidence of antimicrobial resistance. In addition to their role as food biopreservatives, bacteriocins are gaining credibility as health modulators, due to their ability to regulate the gut microbiota, which is strongly associated with human wellbeing. Indeed the strengthening link between the gut microbiota and obesity make bacteriocins ideal alternatives to Animal Growth Promoters (AGP) in animal feed also. Here we review recent advances in bacteriocin research that will contribute to the development of functional foods and feeds as a consequence of roles in food biopreservation and human/animal health.

Identifiants

pubmed: 31968296
pii: S0958-1669(19)30161-2
doi: 10.1016/j.copbio.2019.12.023
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0
Bacteriocins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

160-167

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Paula M O'Connor (PM)

Teagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland; APC Microbiome Ireland, University College Cork, Ireland.

Taís M Kuniyoshi (TM)

Teagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland; Biochemical and Pharmaceutical Technology Department, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Lineu Prestes 580, São Paulo 05508-900, Brazil.

Ricardo Ps Oliveira (RP)

Biochemical and Pharmaceutical Technology Department, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Lineu Prestes 580, São Paulo 05508-900, Brazil.

Colin Hill (C)

APC Microbiome Ireland, University College Cork, Ireland; School of Microbiology, University College Cork, Ireland.

Reynolds Paul Ross (RP)

APC Microbiome Ireland, University College Cork, Ireland; School of Microbiology, University College Cork, Ireland.

Paul D Cotter (PD)

Teagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland; APC Microbiome Ireland, University College Cork, Ireland. Electronic address: paul.cotter@teagasc.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH